DTaP Vaccine Market By Disease Type, Product Type and End User - Global Industry Analysis And Forecast To 2027

Published On : June 2022 Pages : 141 Category: Pharmaceuticals Report Code : HC063860

SEGMENTS & REGIONS:

Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Report Description
Table of Content

DTaP Vaccine Market By Disease Type (Pertussis, Tetanus and Diphtheria), Product Type (Quaracel, Daptacel, Pentacel, Infanrix, Pediarix and Kinrix) and End User (Vaccination Centers, Clinics and Hospitals) - Global Industry Analysis And Forecast To 2027

Industry Outlook

The DTaP is an antibody which helps the kids more youthful than the age 7 increase immunity to three dangerous ailments brought about by the bacteria: whooping cough, tetanus, and diphtheria. Therefore, the DTaP Vaccine Market is anticipated to expand and has tremendous scope during the forecast period. The global DTaP Vaccine Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Drivers & Restrains

The factors encouraging the growth of market are; more rate of birth, increasing popularity of the pertussia vaccination, increasing number of cases related to cases of this disease, increasing research and development in the field of healthcare, etc. Factors affecting the growth can be due to alternate medications.

Regional Insights

The North American region is leading the global DTaP Vaccine Market with US dominating owing to factor like; increasing number of cases related to the diseases, increasing expenditure on the healthcare sector in this region, more development in the healthcare field, etc.

DTaP Vaccine Market, By Region

- North America
U.S.
Canada
Mexico
- Europe
Germany
UK
France
Russia
Italy
Rest of Europe
- Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Rest of Asia-Pacific
- South America
Brazil
Argentina
Columbia
Rest of South America
- Middle East and Africa
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

Emergent Biosolution Inc.
GlaxoSmithKline
AstraZeneca
Sanofi Pasteur
Protein Sciences Corporation
Astellas Pharma US
Novartis AG
Pfizer Inc.
Merch Sharp & Dohme Corp.

Some of the key questions answered by the report are:

What was the market size in 2017 and forecast from 2017 to 2027?
What will be the industry market growth from 2017 to 2027?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o DTaP Vaccine Market, By Disease Type, Estimates and Forecast, 2017-2027 ($Million)

o Pertussis

o Tetanus

o Diphtheria

o DTaP Vaccine Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)

o Quaracel

o Daptacel

o Pentacel

o Infanrix

o Pediarix

o Kinrix

o DTaP Vaccine Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o Vaccination Centers

o Clinics

o Hospitals

o DTaP Vaccine Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o Emergent Biosolution Inc.

o GlaxoSmithKline

o AstraZeneca

o Sanofi Pasteur

o Protein Sciences Corporation

o Astellas Pharma US

o Novartis AG

o Pfizer Inc.

o Merch Sharp & Dohme Corp.

o DTaP Vaccine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o North America

§ North America DTaP Vaccine Market, By Country

o U.S. DTaP Vaccine Market

o Canada DTaP Vaccine Market

o Mexico DTaP Vaccine Market

o Europe

§ Europe DTaP Vaccine Market, By Country

o Germany DTaP Vaccine Market

o UK DTaP Vaccine Market

o France DTaP Vaccine Market

o Russia DTaP Vaccine Market

o Italy DTaP Vaccine Market

o Rest of Europe DTaP Vaccine Market

o Asia-Pacific

§ Asia-Pacific DTaP Vaccine Market, By Country

o China DTaP Vaccine Market

o Japan DTaP Vaccine Market

o South Korea DTaP Vaccine Market

o India DTaP Vaccine Market

o Southeast Asia DTaP Vaccine Market

o Rest of Asia-Pacific DTaP Vaccine Market

o South America

§ South America DTaP Vaccine Market, By Country

o Brazil DTaP Vaccine Market

o Argentina DTaP Vaccine Market

o Columbia DTaP Vaccine Market

o Rest of South America DTaP Vaccine Market

o Middle East and Africa

§ Middle East and Africa DTaP Vaccine Market, By Country

o Saudi Arabia DTaP Vaccine Market

o UAE DTaP Vaccine Market

o Egypt DTaP Vaccine Market

o Nigeria DTaP Vaccine Market

o South Africa DTaP Vaccine Market

o Rest of MEA DTaP Vaccine Market

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market Status and Outlook (2017-2027)

4.1.2. Canada Market Status and Outlook (2017-2027)

4.1.3. Mexico Market Status and Outlook (2017-2027)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market Status and Outlook (2017-2027)

4.2.2. France Market Status and Outlook (2017-2027)

4.2.3. UK Market Status and Outlook (2017-2027)

4.2.4. Russia Market Status and Outlook (2017-2027)

4.2.5. Italy Market Status and Outlook (2017-2027)

4.2.6. Rest of Europe Market Status and Outlook (2017-2027)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market Status and Outlook (2017-2027)

4.3.2. Japan Market Status and Outlook (2017-2027)

4.3.3. Korea Market Status and Outlook (2017-2027)

4.3.4. India Market Status and Outlook (2017-2027)

4.3.5. Southeast Asia Market Status and Outlook (2017-2027)

4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market Status and Outlook (2017-2027)

4.4.2. Argentina Market Status and Outlook (2017-2027)

4.4.3. Columbia Market Status and Outlook (2017-2027)

4.4.4. Rest of South America Market Status and Outlook (2017-2027)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3. Egypt Market Status and Outlook (2017-2027)

4.5.4. Nigeria Market Status and Outlook (2017-2027)

4.5.5. South Africa Market Status and Outlook (2017-2027)

4.5.6. Turkey Market Status and Outlook (2017-2027)

4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5. DTaP Vaccine Market, By Disease Type

5.1. Introduction

5.2. Global DTaP Vaccine Revenue and Market Share by Disease Type (2017-2027)

5.2.1. Global DTaP Vaccine Revenue and Revenue Share by Disease Type (2017-2027)

5.3. Pertussis

5.3.1. Global Pertussis Revenue and Growth Rate (2017-2027)

5.4. Tetanus

5.4.1. Global Tetanus Revenue and Growth Rate (2017-2027)

5.5. Diphtheria

5.5.1. Global Diphtheria Revenue and Growth Rate (2017-2027)

6. DTaP Vaccine Market, By Product Type

6.1. Introduction

6.2. Global DTaP Vaccine Revenue and Market Share by Product Type (2017-2027)

6.2.1. Global DTaP Vaccine Revenue and Revenue Share by Product Type (2017-2027)

6.3. Quaracel

6.3.1. Global Quaracel Revenue and Growth Rate (2017-2027)

6.4. Daptacel

6.4.1. Global Daptacel Revenue and Growth Rate (2017-2027)

6.5. Pentacel

6.5.1. Global Pentacel Revenue and Growth Rate (2017-2027)

6.6. Infanrix

6.6.1. Global Infanrix Revenue and Growth Rate (2017-2027)

6.7. Pediarix

6.7.1. Global Pediarix Revenue and Growth Rate (2017-2027)

6.8. Kinrix

6.8.1. Global Kinrix Revenue and Growth Rate (2017-2027)

7. DTaP Vaccine Market, By End User

7.1. Introduction

7.2. Global DTaP Vaccine Revenue and Market Share by End User (2017-2027)

7.2.1. Global DTaP Vaccine Revenue and Revenue Share by End User (2017-2027)

7.3. Vaccination Centers

7.3.1. Global Vaccination Centers Revenue and Growth Rate (2017-2027)

7.4. Clinics

7.4.1. Global Clinics Revenue and Growth Rate (2017-2027)

7.5. Hospitals

7.5.1. Global Hospitals Revenue and Growth Rate (2017-2027)

8. DTaP Vaccine Market, By Region

8.1. Introduction

8.2. Global DTaP Vaccine Revenue and Market Share by Regions

8.2.1. Global DTaP Vaccine Revenue by Regions (2017-2027)

8.3. North America DTaP Vaccine by Countries

8.3.1. North America DTaP Vaccine Revenue and Growth Rate (2017-2027)

8.3.2. North America DTaP Vaccine Revenue (Million USD) by Countries (2017-2027)

8.3.3. United States

8.3.3.1. United States DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.4. Canada

8.3.4.1. Canada DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.5. Mexico

8.3.5.1. Mexico DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.4. Europe DTaP Vaccine by Countries

8.4.1. Europe DTaP Vaccine Revenue and Growth Rate (2017-2027)

8.4.2. Europe DTaP Vaccine Revenue (Million USD) by Countries (2017-2027)

8.4.3. Germany

8.4.3.1. Germany DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.4. France

8.4.4.1. France DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.5. UK

8.4.5.1. UK DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.6. Russia

8.4.6.1. Russia DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.7. Italy

8.4.7.1. Italy DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.8. Rest of Europe

8.4.8.1. Rest of Europe DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.5. Asia-Pacific DTaP Vaccine by Countries

8.5.1. Asia-Pacific DTaP Vaccine Revenue and Growth Rate (2017-2027)

8.5.2. Asia-Pacific DTaP Vaccine Revenue (Million USD) by Countries (2017-2027)

8.5.3. China

8.5.3.1. China DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.4. Japan

8.5.4.1. Japan DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.5. Korea

8.5.5.1. Korea DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.6. India

8.5.6.1. India DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.7. Southeast Asia

8.5.7.1. Southeast Asia DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.8. Rest of Asia-Pacific

8.5.8.1. Rest of Asia-Pacific DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.6. South America DTaP Vaccine by Countries

8.6.1. South America DTaP Vaccine Revenue and Growth Rate (2017-2027)

8.6.2. South America DTaP Vaccine Revenue (Million USD) by Countries (2017-2027)

8.6.3. Brazil

8.6.3.1. Brazil DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.4. Argentina

8.6.4.1. Argentina DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.5. Columbia

8.6.5.1. Columbia DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.6. Rest of South America

8.6.6.1. Rest of South America DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.7. Middle East and Africa DTaP Vaccine by Countries

8.7.1. Middle East and Africa DTaP Vaccine Revenue and Growth Rate (2017-2027)

8.7.2. Middle East and Africa DTaP Vaccine Revenue (Million USD) by Countries (2017-2027)

8.7.3. Saudi Arabia

8.7.3.1. Saudi Arabia DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.4. United Arab Emirates

8.7.4.1. United Arab Emirates DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.5. Egypt

8.7.5.1. Egypt DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.6. Nigeria

8.7.6.1. Nigeria DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.7. South Africa

8.7.7.1. South Africa DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.8. Turkey

8.7.8.1. Turkey DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.9. Rest of Middle East and Africa

8.7.9.1. Rest of Middle East and Africa DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

9. Company Profiles

9.1. Emergent Biosolution Inc.

9.1.1. Business Overview

9.1.2. Service Portfolio

9.1.3. Strategic Developments

9.1.4. Financial Overview

9.2. GlaxoSmithKline

9.2.1. Business Overview

9.2.2. Service Portfolio

9.2.3. Strategic Developments

9.2.4. Financial Overview

9.3. AstraZeneca

9.3.1. Business Overview

9.3.2. Service Portfolio

9.3.3. Strategic Developments

9.3.4. Financial Overview

9.4. Sanofi Pasteur

9.4.1. Business Overview

9.4.2. Service Portfolio

9.4.3. Strategic Developments

9.4.4. Financial Overview

9.5. Protein Sciences Corporation

9.5.1. Business Overview

9.5.2. Service Portfolio

9.5.3. Strategic Developments

9.5.4. Financial Overview

9.6. Astellas Pharma US

9.6.1. Business Overview

9.6.2. Service Portfolio

9.6.3. Strategic Developments

9.6.4. Financial Overview

9.7. Novartis AG

9.7.1. Business Overview

9.7.2. Service Portfolio

9.7.3. Strategic Developments

9.7.4. Financial Overview

9.8. Pfizer Inc.

9.8.1. Business Overview

9.8.2. Service Portfolio

9.8.3. Strategic Developments

9.8.4. Financial Overview

9.9. Merch Sharp & Dohme Corp.

9.9.1. Business Overview

9.9.2. Service Portfolio

9.9.3. Strategic Developments

9.9.4. Financial Overview

10. DTaP Vaccine Market Forecast (2017-2027)

10.1. Global DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. DTaP Vaccine Market Forecast by Regions (2017-2027)

10.2.1. North America DTaP Vaccine Market Forecast (2017-2027)

10.2.1.1. United States DTaP Vaccine Market Forecast (2017-2027)

10.2.1.2. Canada DTaP Vaccine Market Forecast (2017-2027)

10.2.1.3. Mexico DTaP Vaccine Market Forecast (2017-2027)

10.2.2. Europe DTaP Vaccine Market Forecast (2017-2027)

10.2.2.1. Germany DTaP Vaccine Market Forecast (2017-2027)

10.2.2.2. France DTaP Vaccine Market Forecast (2017-2027)

10.2.2.3. UK DTaP Vaccine Market Forecast (2017-2027)

10.2.2.4. Russia DTaP Vaccine Market Forecast (2017-2027)

10.2.2.5. Italy DTaP Vaccine Market Forecast (2017-2027)

10.2.2.6. Rest of Europe DTaP Vaccine Market Forecast (2017-2027)

10.2.3. Asia-Pacific DTaP Vaccine Market Forecast (2017-2027)

10.2.3.1. China DTaP Vaccine Market Forecast (2017-2027)

10.2.3.2. Japan DTaP Vaccine Market Forecast (2017-2027)

10.2.3.3. Korea DTaP Vaccine Market Forecast (2017-2027)

10.2.3.4. India DTaP Vaccine Market Forecast (2017-2027)

10.2.3.5. Southeast Asia DTaP Vaccine Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific DTaP Vaccine Market Forecast (2017-2027)

10.2.4. South America DTaP Vaccine Market Forecast (2017-2027)

10.2.4.1. Brazil DTaP Vaccine Market Forecast (2017-2027)

10.2.4.2. Argentina DTaP Vaccine Market Forecast (2017-2027)

10.2.4.3. Columbia DTaP Vaccine Market Forecast (2017-2027)

10.2.4.4. Rest of South America DTaP Vaccine Market Forecast (2017-2027)

10.2.5. Middle East and Africa DTaP Vaccine Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia DTaP Vaccine Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates DTaP Vaccine Market Forecast (2017-2027)

10.2.5.3. Egypt DTaP Vaccine Market Forecast (2017-2027)

10.2.5.4. Nigeria DTaP Vaccine Market Forecast (2017-2027)

10.2.5.5. South Africa DTaP Vaccine Market Forecast (2017-2027)

10.2.5.6. Turkey DTaP Vaccine Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa DTaP Vaccine Market Forecast (2017-2027)

10.3. DTaP Vaccine Market Forecast by Disease Type (2017-2027)

10.3.1. DTaP Vaccine Forecast by Disease Type (2017-2027)

10.3.2. DTaP Vaccine Market Share Forecast by Disease Type (2017-2027)

10.4. DTaP Vaccine Market Forecast by Product Type (2017-2027)

10.4.1. DTaP Vaccine Forecast by Product Type (2017-2027)

10.4.2. DTaP Vaccine Market Share Forecast by Product Type (2017-2027)

10.5. DTaP Vaccine Market Forecast by End User (2017-2027)

10.5.1. DTaP Vaccine Forecast by End User (2017-2027)

10.5.2. DTaP Vaccine Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa DTaP Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global DTaP Vaccine Revenue and Revenue Share by Disease Type (2017-2018)
Figure Global Pertussis Revenue and Growth Rate (2017-2018)
Figure Global Tetanus Revenue and Growth Rate (2017-2018)
Figure Global Diphtheria Revenue and Growth Rate (2017-2018)
Table Global DTaP Vaccine Revenue and Revenue Share by Product Type (2017-2018)
Figure Global Quaracel Revenue and Growth Rate (2017-2018)
Figure Global Daptacel Revenue and Growth Rate (2017-2018)
Figure Global Pentacel Revenue and Growth Rate (2017-2018)
Figure Global Infanrix Revenue and Growth Rate (2017-2018)
Figure Global Pediarix Revenue and Growth Rate (2017-2018)
Figure Global Kinrix Revenue and Growth Rate (2017-2018)
Table Global DTaP Vaccine Revenue and Revenue Share by End User (2017-2018)
Figure Global Vaccination Centers Revenue and Growth Rate (2017-2018)
Figure Global Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Table Global DTaP Vaccine Revenue by Regions (2017-2018)
Figure North America DTaP Vaccine Growth Rate (2017-2018)
Figure North America DTaP Vaccine Revenue and Growth Rate (2017-2018)
Figure North America DTaP Vaccine by Countries (2017-2018)
Figure North America DTaP Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure United States DTaP Vaccine Growth Rate (2017-2018)
Figure United States DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada DTaP Vaccine Growth Rate (2017-2018)
Figure Canada DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico DTaP Vaccine Growth Rate (2017-2018)
Figure Mexico DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe DTaP Vaccine Growth Rate (2017-2018)
Figure Europe DTaP Vaccine Revenue and Growth Rate (2017-2018)
Figure Europe DTaP Vaccine by Countries (2017-2018)
Figure Europe DTaP Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Germany DTaP Vaccine Growth Rate (2017-2018)
Figure Germany DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France DTaP Vaccine Growth Rate (2017-2018)
Figure France DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK DTaP Vaccine Growth Rate (2017-2018)
Figure UK DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia DTaP Vaccine Growth Rate (2017-2018)
Figure Russia DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy DTaP Vaccine Growth Rate (2017-2018)
Figure Italy DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe DTaP Vaccine Growth Rate (2017-2018)
Figure Rest of Europe DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific DTaP Vaccine Growth Rate (2017-2018)
Figure Asia-Pacific DTaP Vaccine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific DTaP Vaccine by Countries (2017-2018)
Figure Asia-Pacific DTaP Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure China DTaP Vaccine Growth Rate (2017-2018)
Figure China DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan DTaP Vaccine Growth Rate (2017-2018)
Figure Japan DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea DTaP Vaccine Growth Rate (2017-2018)
Figure Korea DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India DTaP Vaccine Growth Rate (2017-2018)
Figure India DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia DTaP Vaccine Growth Rate (2017-2018)
Figure Southeast Asia DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific DTaP Vaccine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America DTaP Vaccine Growth Rate (2017-2018)
Figure South America DTaP Vaccine Revenue and Growth Rate (2017-2018)
Figure South America DTaP Vaccine by Countries (2017-2018)
Figure South America DTaP Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil DTaP Vaccine Growth Rate (2017-2018)
Figure Brazil DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina DTaP Vaccine Growth Rate (2017-2018)
Figure Argentina DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia DTaP Vaccine Growth Rate (2017-2018)
Figure Columbia DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America DTaP Vaccine Growth Rate (2017-2018)
Figure Rest of South America DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa DTaP Vaccine Growth Rate (2017-2018)
Figure Middle East and Africa DTaP Vaccine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa DTaP Vaccine by Countries (2017-2018)
Figure Middle East and Africa DTaP Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia DTaP Vaccine Growth Rate (2017-2018)
Figure Saudi Arabia DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates DTaP Vaccine Growth Rate (2017-2018)
Figure United Arab Emirates DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt DTaP Vaccine Growth Rate (2017-2018)
Figure Egypt DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria DTaP Vaccine Growth Rate (2017-2018)
Figure Nigeria DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa DTaP Vaccine Growth Rate (2017-2018)
Figure South Africa DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey DTaP Vaccine Growth Rate (2017-2018)
Figure Turkey DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa DTaP Vaccine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa DTaP Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Emergent Biosolution Inc. DTaP Vaccine Financial Overview
Table GlaxoSmithKline DTaP Vaccine Financial Overview
Table AstraZeneca DTaP Vaccine Financial Overview
Table Sanofi Pasteur DTaP Vaccine Financial Overview
Table Protein Sciences Corporation DTaP Vaccine Financial Overview
Table Astellas Pharma US DTaP Vaccine Financial Overview
Table Novartis AG DTaP Vaccine Financial Overview
Table Pfizer Inc. DTaP Vaccine Financial Overview
Table Merch Sharp & Dohme Corp. DTaP Vaccine Financial Overview
Figure Global DTaP Vaccine Revenue (Millions USD) and Growth Rate (2018-2025)
Table DTaP Vaccine Market Forecast by Regions (2018-2025)
Figure North America DTaP Vaccine Market Forecast (2018-2025)
Figure United States DTaP Vaccine Market Forecast (2018-2025)
Figure Canada DTaP Vaccine Market Forecast (2018-2025)
Figure Mexico DTaP Vaccine Market Forecast (2018-2025)
Figure Europe DTaP Vaccine Market Forecast (2018-2025)
Figure Germany DTaP Vaccine Market Forecast (2018-2025)
Figure France DTaP Vaccine Market Forecast (2018-2025)
Figure UK DTaP Vaccine Market Forecast (2018-2025)
Figure Russia DTaP Vaccine Market Forecast (2018-2025)
Figure Italy DTaP Vaccine Market Forecast (2018-2025)
Figure Rest of Europe DTaP Vaccine Market Forecast (2018-2025)
Figure Asia-Pacific DTaP Vaccine Market Forecast (2018-2025)
Figure China DTaP Vaccine Market Forecast (2018-2025)
Figure Japan DTaP Vaccine Market Forecast (2018-2025)
Figure Korea DTaP Vaccine Market Forecast (2018-2025)
Figure India DTaP Vaccine Market Forecast (2018-2025)
Figure Southeast Asia DTaP Vaccine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific DTaP Vaccine Market Forecast (2018-2025)
Figure South America DTaP Vaccine Market Forecast (2018-2025)
Figure Brazil DTaP Vaccine Market Forecast (2018-2025)
Figure Argentina DTaP Vaccine Market Forecast (2018-2025)
Figure Columbia DTaP Vaccine Market Forecast (2018-2025)
Figure Rest of South America DTaP Vaccine Market Forecast (2018-2025)
Figure Middle East and Africa DTaP Vaccine Market Forecast (2018-2025)
Figure Saudi Arabia DTaP Vaccine Market Forecast (2018-2025)
Figure United Arab Emirates DTaP Vaccine Market Forecast (2018-2025)
Figure Egypt DTaP Vaccine Market Forecast (2018-2025)
Figure Nigeria DTaP Vaccine Market Forecast (2018-2025)
Figure South Africa DTaP Vaccine Market Forecast (2018-2025)
Figure Turkey DTaP Vaccine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa DTaP Vaccine Market Forecast (2018-2025)
Figure Global DTaP Vaccine Forecast by Disease Type (2018-2025)
Figure Global DTaP Vaccine Market Share Forecast by Disease Type (2018-2025)
Figure Global DTaP Vaccine Forecast by Disease Type (2018-2025)
Figure Global DTaP Vaccine Forecast by Product Type (2018-2025)
Figure Global DTaP Vaccine Market Share Forecast by Product Type (2018-2025)
Figure Global DTaP Vaccine Forecast by Product Type (2018-2025)
Figure Global DTaP Vaccine Forecast by End User (2018-2025)
Figure Global DTaP Vaccine Market Share Forecast by End User (2018-2025)
Figure Global DTaP Vaccine Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

Number of patients for particular device or medical procedure and
Repeated use of particular device depending on health and condition of patient

Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country

Request Sample Enquire Before Buying Request for Customization

Request Sample

Requirement/Comment